Prevalence And Impact of Medical Comorbidities in A Real‐World Lung Cancer Screening Population-Reference-Cited by-同舟云学术

Prevalence And Impact of Medical Comorbidities in A Real‐World Lung Cancer Screening Population

Published:2022-07 Issue:5 Volume:23 Page:419-427
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Majeed Harris^ORCID,Zhu Hong^ORCID,Williams Sarah A.^ORCID,Hamann Heidi A.,Natchimuthu Vijaya Subbu,Lee Jessica^ORCID,Santini Noel O.^ORCID,Browning Travis^ORCID,Prasad Tanushree,Adesina Joyce O.^ORCID,Do Minh,Balis David^ORCID,de Willams Juana Gamarra,Kitchell Ellen,Johnson David H.,Lee Simon J. Craddock,Gerber David E.^ORCID

Funder

National Institutes of Health

National Cancer Institute

Cancer Prevention and Research Institute of Texas

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference54 articles.

1. Screening for lung cancer: U.S. Preventive services task force recommendation statement;Moyer;Ann Intern Med,2014

2. Measuring the health hazards of tobacco: commentary;Lopez;Bull World Health Organ,1999

3. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study;Jacobs;Arch Intern Med,1999